Recursion
Biotech · United States · Founded 2013 · public · RXRX
Recursion has been industrialising cell-image biology since 2013 and its most advanced medicine, REC-4881, is still a Phase 1b/2 in an orphan bowel condition whose registrational path it was only discussing with the FDA in 2026.
The record
4 figures · 0 rounds · 0 backers · 1 feed items
Every one of them carries its source, its date, and its age when it has one. Reading the record takes a free account; the account is how you keep a watchlist.